Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The thymus in myasthenia gravis

R Hohlfeld¹, H Wekerle

¹Department of Neuroimmunology, Max-Planck-Institute of Psychiatry, Martinsried, Germany.

Neurologic Clinics

|May 1, 1994

Summary

Myasthenia Gravis (MG) pathogenesis begins in the thymus, where B cells produce autoantibodies targeting the acetylcholine receptor (AChR). Thymomas may trigger MG via molecular mimicry involving AChR epitopes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis - Commentary.

Multiple sclerosis (Houndmills, Basingstoke, England)·2021

Same author

Nature, nurture, and microbes: The development of multiple sclerosis.

Acta neurologica Scandinavica·2017

Same author

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.

Journal of neurology·2016

Same author

[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].

Der Nervenarzt·2016

Same author

[Current aspects of therapy conversion for multiple sclerosis].

Der Nervenarzt·2015

Same author

[Immunotherapies for multiple sclerosis : review and update].

Der Internist·2015

Area of Science:

Immunology
Neurology
Pathogenesis Research

Background:

Myasthenia Gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
The thymus plays a critical role in immune system development and tolerance.
Previous research suggests thymic abnormalities in MG patients.

Purpose of the Study:

To investigate the role of the thymus in the pathogenesis of Myasthenia Gravis.
To identify the cellular and molecular mechanisms initiating MG within the thymus.

Main Methods:

Analysis of thymic tissue from MG patients.
Identification of B cells and antigen-presenting cells within the thymus.
Investigation of potential autoantigen sources in thymomas.

Main Results:

Thymuses from most MG patients contain B cells producing acetylcholine receptor (AChR)-specific autoantibodies.
Hyperplastic thymuses show germinal centers with AChR-producing cells and dendritic cells.
Thymomas may express proteins with shared epitopes to AChR, potentially initiating MG through molecular mimicry.

Conclusions:

The thymus is the primary site for initiating Myasthenia Gravis pathogenesis.
AChR autoantibody production by thymic B cells is a key feature of MG.
Molecular mimicry involving thymoma-associated antigens may trigger thymoma-associated MG.

Related Experiment Videos